The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEqtec Regulatory News (EQT)

Share Price Information for Eqtec (EQT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.85
Bid: 1.80
Ask: 1.90
Change: 0.00 (0.00%)
Spread: 0.10 (5.556%)
Open: 1.85
High: 1.85
Low: 1.85
Prev. Close: 1.85
EQT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Acquisition and Date of Admission

22 Dec 2017 10:06

RNS Number : 2111A
EQTEC PLC
22 December 2017
 

 

22 December 2017

 

EQTEC plc

("EQTEC" or the "Company")

 

 

Update on Acquisition and Date of Admission

 

 

Further to the announcement of 19 December 2017, EQTEC plc (AIM: EQT), the technology solution company for waste gasification to energy projects, announces that Admission, being the final condition to completion of the Acquisition and the Placing, will take place at 8.00 a.m. on 28 December 2017.

 

The table below shows a breakdown of the Placing Shares, Consideration Shares, and Ordinary Shares to be issued on Admission pursuant to a convertible loan agreement (the "Conversion Shares") (collectively "the New Shares").

 

 

Placing Shares

246,153,847

Consideration Shares

833,864,531

Conversion Shares

80,769,231

Total

1,160,787,609

 

Accordingly application has been made for admission of the New Shares to trading on AIM. Admission of the 1,160,787,609 New Shares will take place on 28 December 2017.

 

Following the issue of the Consideration Shares to the Vendors, EBIOSS will be interested in 676,406,371 Ordinary Shares and Inava will be interested in 250,159,360 Ordinary Shares being 50.25% and 18.58% respectively of the Enlarged Share Capital.

 

Following Admission, the Company will have 1,346,090,838 Ordinary Shares of €0.001 in issue. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of voting rights in the Company is 1,346,090,838 and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Capitalised terms used in this announcement bear the meaning given to them in the Company's admission document dated 27 November 2017.

 

 

Enquiries

 

EQTEC plc

+353 (0)21 2409 056

Gerry Madden/Brendan Halpin

Northland Capital Partners Limited - Nomad and Joint Broker

+44 (0)20 3861 6625

Tom Price / Dugald J. Carlean

SVS Securities Plc - Joint Broker

+44 (0)20 3700 0093

Tom Curran / Ben Tadd

VSA Capital Limited - Financial Adviser and Joint Broker

+44 (0)20 3005 5000

Andrew Monk / Andrew Raca

Luther Pendragon - Financial PR

+44 (0)20 7618 9100

Harry Chathli / Alexis Gore / Ana Ribeiro

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCOKBDKKBDDNBB
Date   Source Headline
19th Apr 20247:45 amRNSUpdate on Verde Corporation Subscription
5th Apr 202410:13 amRNSHolding(s) in Company
3rd Apr 20243:09 pmRNSSettlement Agreement with Logik Developments
2nd Apr 20247:00 amRNSUpdate on Verde Corporation Subscription
11th Mar 20247:00 amRNSUpdate on Verde Corporation Subscription
29th Feb 20247:17 amRNSUpdate on Initial Subscription
22nd Feb 20248:09 amRNSUpdate on Initial Subscription
13th Feb 20245:00 pmRNSHolding(s) in Company
13th Feb 20248:17 amRNSHolding(s) in Company
13th Feb 20247:00 amRNSNew Investor Subscription and Debt Conversion
16th Jan 20241:16 pmRNSJoint Venture with CompactGTL
16th Jan 20247:00 amRNSDrawdown of Bank Refinance Approved for Italy MDC
21st Dec 20237:00 amRNSItaly MDC - Refinance Update & Conversion Notices
18th Dec 20231:30 pmRNSResults of EGM
7th Dec 20237:00 amRNSEquipment Supply Agreement for Plant in USA
29th Nov 20237:00 amRNSTechnical Services Agreement for Plant in USA
28th Nov 20237:00 amRNSAchievement of ISO certifications
27th Nov 20237:00 amRNSCollaboration Framework Agreement
24th Nov 20237:00 amRNSNotice of EGM
20th Nov 20237:00 amRNSRefinancing of Debt Facilities and Company Update
6th Nov 20238:39 amRNSItalia MDC update and share ownership
16th Oct 20237:00 amRNSDirector/PDMR Shareholding
13th Oct 20234:28 pmRNSDirector/PDMR Shareholding
6th Oct 202310:55 amRNSHolding(s) in Company
4th Oct 20237:00 amRNSDirector/PDMR Shareholding
2nd Oct 20232:25 pmRNSDirector Dealing
28th Sep 20237:00 amRNSInterim results
26th Sep 20237:00 amRNSProject update
20th Sep 20234:15 pmRNSLegal claim against Logik Developments
20th Sep 202312:25 pmRNSDiscontinuation of Billingham Project
4th Sep 20237:00 amRNSBank Refinance of Italy Market Development Centre
17th Aug 20237:00 amRNSContract signed with Idex for FEED at France MDC
31st Jul 20237:00 amRNSSuccessful Steam-Oxygen Gasification Tests
25th Jul 20237:00 amRNSCollaboration Framework Agreement with Domi Ost
12th Jul 20237:00 amRNSSale of France Market Development Centre to Idex
23rd Jun 20239:40 amRNSGrant of Long-term Incentive Plan Options
22nd Jun 202312:55 pmRNSCompletion of Italy MDC handover
21st Jun 20234:15 pmRNSResults of 2023 AGM
25th May 20237:00 amRNSNotice of 2023 AGM
5th May 20237:00 amRNSFinal Results
21st Apr 20234:30 pmRNSResult of Broker Option
18th Apr 20237:00 amRNSPublication of 2022 annual report
17th Apr 20232:15 pmRNSCollaboration Framework Agreement
4th Apr 20237:00 amRNSUpdate re Director remuneration and Broker Option
27th Mar 20237:00 amRNSFrance project award with Idex Group
23rd Mar 20237:00 amRNSFrance government award for potential RNG project
21st Mar 202311:05 amRNSSecond Price Monitoring Extn
21st Mar 202311:00 amRNSPrice Monitoring Extension
21st Mar 20238:14 amRNSProposed Equity Issue to raise approximately £3.5m
14th Mar 20234:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.